Related Experiment Video
Updated: May 9, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Clinical and prothrombotic profile of hepatic vein outflow tract obstruction
Seema Alam1, Rajeev Khanna, Amar Mukund
1Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, D-1 Vasant Kunj, New Delhi, 110070, India, seema_alam@hotmail.com.
Insights
Hepatic venous outflow tract obstruction (HVOTO) in children often presents with ascites and edema. Prothrombotic factors, particularly MTHFR mutations, are common causes, and treatments like angioplasty or TIPSS are effective.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Vascular Medicine
Background:
- Hepatic venous outflow tract obstruction (HVOTO) is a critical condition in pediatric liver disease.
- Understanding its clinical presentation and prothrombotic profile is essential for timely diagnosis and management.
Purpose of the Study:
- To investigate the clinical features, prothrombotic causes, and outcomes of pediatric hepatic venous outflow tract obstruction (HVOTO).
- To identify common genetic mutations and risk factors associated with HVOTO in children.
Main Methods:
- Prospective cohort study of pediatric patients with acute or chronic liver disease.
- Screening for HVOTO using ultrasound, Doppler imaging, and contrast-enhanced multidetector computed tomography (MDCT).
- Genetic testing for prothrombotic mutations, including MTHFR and Factor V Leiden.
Main Results:
- 13 out of 162 (7.4%) children with chronic liver disease were diagnosed with HVOTO.
- Ascites and pedal edema were the most common clinical signs.
- Prothrombotic causes were identified in 10 out of 13 cases (76.9%), with MTHFR gene mutations being the most frequent.
- Interventions such as angioplasty and transjugular intrahepatic portosystemic shunt (TIPSS) led to asymptomatic outcomes with improved growth.
Conclusions:
- Clinical signs like ascites, pedal edema, and hepatomegaly should prompt suspicion of HVOTO in pediatric liver disease.
- A significant majority of HVOTO cases in children have an underlying prothrombotic cause, with MTHFR mutations being prevalent.
- Angioplasty and TIPSS are effective treatment modalities for managing pediatric HVOTO, leading to favorable patient outcomes.
Objective:
To study the clinical as well as prothrombotic profile and outcome of hepatic venous outflow tract obstruction in children.
Methods:
This is a prospective study of a cohort of hepatic venous outflow tract obstruction (HVOTO) pediatric cases. All children and adolescents presenting with acute or chronic liver disease were screened for HVOTO with ultrasound and Doppler imaging and confirmed by multidetector computerised tomography (MDCT) with contrast enhancement.
Results:
Of the 162 cases of chronic liver disease, 13 (7.4 %) were diagnosed to have HVOTO. Ascites and edema over the feet were the most prominent features. Anabolic steroids and herbal drugs were being taken by one case each. Six cases were diagnosed on Doppler and for rest 7 cases conclusive diagnosis was made on multidetector computerised tomography. Five out of 13 cases were heterogenous (CT) for mutation of the gene encoding methylene tetrahydrofolate reductase (MTHFR) and one case of these was also heterogenous for Factor Leiden V. One case was known celiac and developed HVOTO and was also found to be having hepatocellular carcinoma. Other causes were drug induced, pressure on inferior vena cava (IVC) and inferior vena cava (IVC) web. Thus the authors could find a prothrombotic cause for 10 out of 13 (76.9 %) cases. Three cases did not need any intervention. In one patient with infective thrombus of the IVC intervention was not planned. Six underwent angioplasty and 3 underwent transjugular intrahepatic portosystemic shunt. All were asymptomatic with improving growth parameters at follow up.
Conclusions:
Ascites, pedal edema, prominent abdominal veins and hepatomegaly should raise the suspicion of HVOTO in childhood liver disease. Majority of the cases would be harbouring a prothrombotic cause. MTHFR mutation was the commonest cause of HVOTO in the present study. Angioplasty and/or transjugular intrahepatic portosystemic shunt (TIPSS) can successfully treat HVOTO.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Portal Hypertension
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

